semaglutide lowers risk of heart issues regardless of weight loss Ozempic and Mounjaro: Saving Your BEFORE the Scale Moves GLP-1 drugs' heart health benefits

Personalized Approach: Avoid one-size-fits-all solutions

Based on these findings, the FDA expanded Wegovys (semaglutide 2.4 mg) approval to include cardiovascular risk reduction

I think a way to summarize that is a lot of the low hanging fruit has been picked

Neuroendocrine experiments use pituitary cell cultures (GH3, AtT-20) and primary pituitary tissue explants to measure peptide release in response to DSIP

While this mechanism can result in weight loss, it can also lead to gastrointestinal side effects such as: Nausea Diarrhea Vomiting Bloating Abdominal pain Constipation Sulfur burps (foul, rotten-egg-smelling burps) Acid reflux These adverse effects can be worsened if you overeat past the point of feeling full

Its especially important for cells in your heart